We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.75 | 1.96% | 39.00 | 299,065 | 16:35:01 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 38.00 | 39.50 | 40.25 | 38.75 | 39.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 94.51 | 48.76M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 17:07:57 | O | 5,000 | 39.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/4/2024 | 09:18 | ALNC |  Venture Life renews revolving credit facility with Santander and HSBC |
| 19/4/2024 | 07:00 | UK RNS | Venture Life Group PLC RCF in Place and New Partner in the USA |
| 09/4/2024 | 12:16 | ALNC | Venture Life to benefit from higher prices as profit surges in 2023 |
| 09/4/2024 | 07:00 | UK RNS | Venture Life Group PLC Final Results for year ended 31 December 2023 |
| 04/4/2024 | 07:00 | UK RNS | Venture Life Group PLC Notice of Results and Investor Presentation |
| 19/2/2024 | 17:18 | UK RNS | Venture Life Group PLC Holding(s) in Company |
| 06/2/2024 | 10:48 | UK RNS | Venture Life Group PLC Holding(s) in Company |
| 01/2/2024 | 12:03 | ALNC | Venture Life credits success to portfolio "robustness and variety" |
| 01/2/2024 | 07:00 | UK RNS | Venture Life Group PLC Trading Update |
| 20/12/2023 | 14:00 | UKREG | Venture Life Group PLC Holding(s) in Company |
Venture Life (VLG) Share Charts1 Year Venture Life Chart |
|
1 Month Venture Life Chart |
Intraday Venture Life Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 19/4/2024 | 14:55 | Venture Life Group plc | 1,860 |
| 20/3/2024 | 22:22 | ValueGrowth Investing | 35,074 |
| 02/4/2015 | 10:58 | Venture Life Group - Intro video | - |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-04-19 16:07:57 | 39.00 | 5,000 | 1,950.00 | O |
| 2024-04-19 15:35:01 | 39.00 | 5,000 | 1,950.00 | UT |
| 2024-04-19 14:30:07 | 39.00 | 25,000 | 9,750.00 | O |
| 2024-04-19 11:34:27 | 38.63 | 20,000 | 7,726.00 | O |
| 2024-04-19 11:02:47 | 39.23 | 50,000 | 19,612.50 | O |
| Top Posts |
|---|
Posted at 19/4/2024 09:20 by Venture Life Daily Update Venture Life Group Plc is listed in the Misc Retail Stores, Nec sector of the London Stock Exchange with ticker VLG. The last closing price for Venture Life was 38.25p.Venture Life currently has 125,831,530 shares in issue. The market capitalisation of Venture Life is £48,759,718. Venture Life has a price to earnings ratio (PE ratio) of 94.51. This morning VLG shares opened at 39p |
Posted at 19/4/2024 14:47 by celeritas Yep, a great rns today.. Improvement in RCF terms, we have gone from 2.5% above sonia to 2.2% and it won't be that long before it's 2%As I have mentioned before the US is a massive market for VLG to go at and this is just the start, well done vlg. |
Posted at 19/4/2024 07:13 by rivaldo Good to see the new RCF now agreed - and also:"New Partner in USA The Company also announces that it has finalised an exclusive long-term license and distribution deal in the United States for Gelclair, an FDA-approved oral mucositis prescription product, with Jaguar Health (NASDAQ:JAGX). This agreement, spanning 5 years, entails license fees, royalties, and product revenue payments to the Company. "We are really pleased to have partnered Gelclair in the USA, a market where Gelclair has been present for many years," said Jerry Randall, CEO of VLG. "This new agreement will ensure the continued supply of Gelclair to US oncology patients suffering oral mucositis, and generate meaningful additional revenues for the Company in the future." |
Posted at 09/4/2024 08:24 by qs99 Thanks Brummy, especially your opening few paras, wonder therefore if VC world will hoover VLG up in 2024 then?market marked VLG down on these results, perhaps management will want to take it private? DYOR |
Posted at 09/4/2024 07:42 by rivaldo Certainly reads well on first look, with 5.21p adjusted EPS, net debt falling nicely, selling prices across key VLG brands in UK retail increased by almost 10% this year and a very bullish outlook:"I am delighted to announce another successful year for Venture Life Group, marked by significant commercial achievements and strengthened financial positions. Our strategic emphasis on organic growth and cash generation led to a faster reduction in net debt despite challenging market conditions. We have made notable inroads in new product development, resulting in increased revenue and showcasing our innovative in-house R&D capabilities. Furthermore, enhanced branding and marketing efforts have expanded the reach of our 9 key brands to a broader global audience, further propelling our growth trajectory. With a strong commitment to improving EBITDA margins, successful new product launches, and digital transformation initiatives, we are well-positioned for sustained success in 2024 and beyond." |
Posted at 05/4/2024 15:37 by celeritas There's just so many markets to go at for VLG with their products. Debrox sold 4.1m units in the US and that contains Carbamide Peroxide, certainly not something I would stick in my ear... Balance activ has got huge markets to go at, feminine hygiene is worth nearly $5billion in the US alone.Its worth $1.6billion in Brazil, a market they have started to enter.. Our UK market is worth $780m for feminine hygiene, so it shows you what they have to go at. |
Posted at 05/4/2024 09:42 by lammylover FTSE100 down 1%, nervous holders, people taking profits at tax year end etc - normal stuff with market makers using fear to open up spreads, walking down some AIM shares in big steps to shake out weak hands, acquire dirt cheap shares...For others, its a buying day! Just picked up some W7L cheaply. FY results due April. TU for year end was good. Next week buyers will return to market with new tax year and fill their ISAs up. VLG results out Tuesday - anything decent should see the share price re-rate to 50p, I reckon. |
Posted at 04/4/2024 08:49 by lammylover You're right basem! - Its the reality of AIM at the moment. Too many PIs either have taken money out of shares in pursuit of higher returns in the building society or from funds, like Downing Micro Cap who are closing down and returning money to investors.And yet the situation in the UK is so bright for shares this year. Falling inflation, expectant lower interest rates, dirt cheap valuations and either companies being re-rated OR taken over at a premium, a high probability. PIs will return, when the building society rates fall, but by then all the bargain shares (lowly rated profitable businesses, turnaround stocks like VLG etc) will be at much higher prices or been taken out by private equity. You are right to be bullish here and load up while you can. |
Posted at 20/3/2024 11:54 by rivaldo Good to see the share price moving upwards in the run-up to the results in "early April" - last year's were on 4th April, so not long to wait.As a reminder, the positive trading update concluded: "Benefiting from our robust growth, clear strategic priorities aimed at refining our operation, substantial generation of free cashflow and a strong balance sheet, we are now in a prime position to deliver strong shareholder returns and I look forward to presenting the FY23 results to shareholders in April" |
Posted at 08/2/2024 12:57 by celeritas Slater is building for a reason... Once the jigsaw is complete I reckon vlg will be sold which is very likely the name of the game regarding Slater.. VLG have lots of great products now, many are growing really well with loads of new territories to go at and partner deals to be done... The share price is ridiculous really and Slater knows it.. |
Posted at 01/2/2024 10:00 by stemis You'd have though a P/E of at least 8 on 2023 would be achievable, giving a share price of 43p, rising to 51p if they hit their 2024 numbers... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
